Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
出版年份 2015 全文链接
标题
Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
作者
关键词
-
出版物
Oncogenesis
Volume 4, Issue 3, Pages e145-e145
出版商
Springer Nature
发表日期
2015-03-30
DOI
10.1038/oncsis.2015.2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phosphorylation of PAX3 contributes to melanoma phenotypes by affecting proliferation, invasion, and transformation
- (2014) Aditi S. Iyengar et al. Pigment Cell & Melanoma Research
- Glycogen synthase kinase 3 inhibitors induce the canonical WNT/ -catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma
- (2014) E. Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma
- (2014) M G Dionyssiou et al. Cell Death & Disease
- Lithium Chloride and Inhibition of Glycogen Synthase Kinase 3β as a Potential Therapy for Serous Ovarian Cancer
- (2013) Akiva P. Novetsky et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group
- (2013) Brenda Weigel et al. PEDIATRIC BLOOD & CANCER
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
- (2013) Ashley R. P. Hinson et al. Frontiers in Oncology
- Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas
- (2012) P. G. Casali ANNALS OF ONCOLOGY
- Identification of CK2 as the kinase that phosphorylates Pax3 at Ser209 in early myogenic differentiation
- (2012) Aditi S. Iyengar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- P-cadherin is a direct PAX3–FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness
- (2012) S Thuault et al. ONCOGENE
- Phase 1 clinical trials for sarcomas: the cutting edge
- (2011) Vivek Subbiah et al. CURRENT OPINION IN ONCOLOGY
- Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation
- (2011) Kevin N. Dietz et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling
- (2010) Bin Fang et al. BIOCHEMICAL PHARMACOLOGY
- Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y
- (2010) Ayhan Bilir et al. JOURNAL OF NEURO-ONCOLOGY
- Glycogen synthase kinase 3 regulates PAX3–FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells
- (2009) Fu-Yue Zeng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phosphorylation of Serine 205 by the Protein Kinase CK2 Persists on Pax3-FOXO1, but Not Pax3, throughout Early Myogenic Differentiation
- (2009) Kevin N. Dietz et al. BIOCHEMISTRY
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005
- (2009) Simona Ognjanovic et al. CANCER
- PAX3–FOXO1 fusion gene in rhabdomyosarcoma
- (2008) Corinne M. Linardic CANCER LETTERS
- Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
- (2008) Jia Luo CANCER LETTERS
- Phosphorylation Regulates Transcriptional Activity of PAX3/FKHR and Reveals Novel Therapeutic Possibilities
- (2008) R. Amstutz et al. CANCER RESEARCH
- Identification of serine 205 as a site of phosphorylation on Pax3 in proliferating but not differentiating primary myoblasts
- (2008) Patrick J. Miller et al. PROTEIN SCIENCE
- Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma
- (2007) Ken Kikuchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search